Senior insider sale
PRESIDENT & CFO at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$18.74M
321.27K shares
What this filing means
MORTIMER IAN plans to sell 321.27K shares of XENON PHARMACEUTICALS INC. valued at approximately $18.74M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/10/2026ACC: 0001193125-26-100797
Officer· PRESIDENT & CFO
Since Sep 2019
321.27K
Shares to sell
$18.74M
Approx. market value
20K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Performance share unit award vesting
N/A
3/9/2026
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/9/2026 | Performance share unit award vesting N/A | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
270K
Market value
$16.29M
3/9/2026
—Completed
Units to sell
40K
Market value
$1.78M
1/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
11.27K
Market value
$677.4K
3/10/2026
Total
Units
321.27K
Value
$18.74M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/9/2026 | 270K | $16.29M | — | Completed |
1/2/2026 | 40K | $1.78M | — | Completed |
| Planned — Approximate Date | ||||
3/10/2026 | 11.27K | $677.4K | NASDAQ | Planned |
| Total | 321.27K | $18.74M | ||